NCT04694911View on ClinicalTrials.gov

Development of the Oncology Opportunity Cost Assessment Tool

CompletedOBSERVATIONAL
Enrollment

40

Participants

Timeline

Start Date

November 21, 2019

Primary Completion Date

May 11, 2021

Study Completion Date

July 31, 2021

Conditions
Hematopoietic and Lymphoid Cell NeoplasmMalignant Solid Neoplasm
Interventions
BEHAVIORAL

Focus Group

Participate in focus group

OTHER

Interview

Complete cognitive interview

OTHER

Research or Clinical Assessment Tool

Receive OOCAT

Trial Locations (1)

19107

Sidney Kimmel Cancer Center at Thomas Jefferson University, Philadelphia

All Listed Sponsors
lead

Thomas Jefferson University

OTHER

NCT04694911 - Development of the Oncology Opportunity Cost Assessment Tool | Biotech Hunter | Biotech Hunter